HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mengdi Shang Selected Research

ZIF-90

2/2022Dual antisense oligonucleotide targeting miR-21/miR-155 synergize photodynamic therapy to treat triple-negative breast cancer and inhibit metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mengdi Shang Research Topics

Disease

2Neoplasms (Cancer)
02/2022 - 12/2019
1Triple Negative Breast Neoplasms
02/2022
1Neoplasm Metastasis (Metastasis)
02/2022
1Bites and Stings (Sting)
01/2022
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Inflammation (Inflammations)
01/2020

Drug/Important Bio-Agent (IBA)

1Nanoparticle Drug Delivery SystemIBA
02/2022
1Antisense OligonucleotidesIBA
02/2022
1Photosensitizing Agents (Photosensitizers)IBA
02/2022
1MicroRNAs (MicroRNA)IBA
02/2022
1ZIF-90IBA
02/2022
1Adenosine Monophosphate (AMP)IBA
01/2022
12',3'-cyclic GMPIBA
01/2022
1Nucleosomes (Nucleosome)IBA
01/2020
1NitrogenIBA
12/2019
1DNA (Deoxyribonucleic Acid)IBA
12/2019

Therapy/Procedure

2Drug Therapy (Chemotherapy)
02/2022 - 12/2019
2Therapeutics
02/2022 - 01/2022
1Photochemotherapy (Photodynamic Therapy)
02/2022